SPOT-MAS 10
Blood-based multi-cancer screening test using cfDNA methylation and fragmentomic signals with machine learning.
- Developer
- Gene Solutions
- Intended use
- Multi Cancer Screening
- Cancer scope
- Biliary tract cancer, Breast cancer, Colorectal cancer, Endometrial cancer, Esophageal cancer, Head and neck cancer, Liver cancer, Lung cancer, Ovarian cancer, Pancreatic cancer, Stomach cancer
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA methylation, Fragmentomics
- Current version
- SPOT-MAS 10 current configuration (2026)
- Evidence context
- 1 structured studies · 5 indexed performance results · 3 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.